Stock Events

Stock Events

InspireMD 

0
48
+€0.00+0% 00:00 Today

Statistics

Day High
-
Day Low
-
52W High
-
52W Low
-
Volume
-
Avg. Volume
-
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

Nov 12Expected
Q1 2026
Q2 2026
Next
-0.17
-0.16
-0.15
-0.14
Expected EPS
-0.1376010342
Actual EPS
N/A

Financials

-545.82%Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
7.76MRevenue
-42.33MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow II2Q.STU. It's not an investment recommendation.
Tesla
12
TSLA
Apple
10
AAPL
AMD
10
AMD
AT&T
10
T

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Abbott Laboratories
ABT
Mkt Cap183.77B
Abbott Laboratories competes with InspireMD in the cardiovascular device market, particularly in stents and vascular products.
Boston Scientific
BSX
Mkt Cap60.84B
Boston Scientific Corporation offers a wide range of medical devices including those for interventional cardiology, competing directly with InspireMD's stent products.
Medtronic
MDT
Mkt Cap123.49B
Medtronic plc provides medical devices for various healthcare needs, including cardiac and vascular therapies, directly competing with InspireMD's offerings.
Staar Surgical
STAA
Mkt Cap1.23B
STAAR Surgical Company specializes in implantable lenses and delivery systems, competing in the broader market of medical devices for cardiovascular and related conditions.
Johnson & Johnson
JNJ
Mkt Cap657.68B
Johnson & Johnson, through its medical device segment, competes across multiple areas including the manufacture of stents, directly challenging InspireMD.
Stryker
SYK
Mkt Cap111.95B
Stryker Corporation offers products in orthopaedics, medical and surgical, and neurotechnology and spine, which includes vascular technologies competing with InspireMD.
Edwards Lifesciences
EW
Mkt Cap53.03B
Edwards Lifesciences Corporation specializes in heart valves and hemodynamic monitoring, competing in the cardiovascular market alongside InspireMD.
Zimmer Biomet
ZBH
Mkt Cap18.03B
Zimmer Biomet Holdings, Inc. competes in the manufacture of medical devices for musculoskeletal healthcare, which includes vascular and related products.
Integra Lifesciences
IART
Mkt Cap991.6M
Integra LifeSciences Holdings Corporation offers products in neurosurgery, surgical instrumentation, and orthopedics, indirectly competing with InspireMD in the broader medical device market.
Globus Medical
GMED
Mkt Cap10.48B
Globus Medical, Inc. focuses on musculoskeletal solutions, including innovative spinal and orthopedic implants, competing in the medical device market that also covers vascular health solutions.

About

InspireMD Inc is a United States-based medical device company. It is focused on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of complex vascular and coronary disease. The products of the company are the CGuard carotid Embolic Prevention System (CGuard EPS) and the MGuard Prime Embolic Protection System. It generates the majority of the revenue from the sales of CGuard EPS, which combines MicroNet and a self-expandable nitinol stent in a single device for use in carotid artery applications. The Company has one operating and reporting segment that develops, manufactures, and markets products for the treatment of carotid artery disease and other vascular diseases, including the Company's proprietary CGuard stent platform.
Show More
CEO
Marvin L. Slosman
Employees
127
Country
United States
ISIN
US45779A8532
WKN
000A3CMP3

Listings

MU
DE
II2Q.MU
STU
DE
II2.STU
STU
DE
II2N.STU
MU
DE
II2.MU

0 Comments

Share your thoughts

FAQs

What is InspireMD stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Boerse Stuttgart exchange InspireMD stocks are traded under the ticker II2Q.STU.
When is the next InspireMD earnings date?▼
InspireMD is going to release the next earnings report on November 12, 2026.
What were InspireMD earnings last quarter?▼
II2Q.STU earnings for the last quarter are -0.15 EUR per share, whereas the estimation was -0.17 EUR resulting in a +15% surprise. The estimated earnings for the next quarter are N/A EUR per share.
What is InspireMD revenue for the last year?▼
InspireMD revenue for the last year amounts to 7.76M EUR.
What is InspireMD net income for the last year?▼
II2Q.STU net income for the last year is -42.33M EUR.
How many employees does InspireMD have?▼
As of November 7, 2026, the company has 127 employees.
In which sector is InspireMD located?▼
InspireMD operates in the Health & Wellness sector.
When did InspireMD complete a stock split?▼
The last stock split for InspireMD was on April 27, 2021 with a ratio of 1:15.
Where is InspireMD headquartered?▼
InspireMD is headquartered in MIAMI, United States.